More recently, Oh et al (53) identified multiple cytotoxic CD4+ T cell subsets within human bladder tumors that killed autologous tumors in an HLA class II-restricted manner and whose presence was predictive of clinical response to anti-PD-L1 in those with metastatic disease. The gene discussed is CD4; the disease is metastatic neoplasm.